HY-129476-1mg
|
MedChemexpress LLC
|
L-Canaline [CAS 496-93-5]
|
|
COVID-19-immunoregulation
|
|
HY-129476-5mg
|
MedChemexpress LLC
|
L-Canaline [CAS 496-93-5]
|
|
COVID-19-immunoregulation
|
|
HY-18076-10mg
|
MedChemexpress LLC
|
LPA1 receptor antagonist 1 [CAS 1396006-71-5]
|
|
COVID-19-immunoregulation
|
|
HY-18076-5mg
|
MedChemexpress LLC
|
LPA1 receptor antagonist 1 [CAS 1396006-71-5]
|
|
COVID-19-immunoregulation
|
|
HY-107765-10mg
|
MedChemexpress LLC
|
LY2955303 [CAS 1433497-19-8]
|
|
COVID-19-immunoregulation
|
|
HY-107765-25mg
|
MedChemexpress LLC
|
LY2955303 [CAS 1433497-19-8]
|
|
COVID-19-immunoregulation
|
|
HY-107765-5mg
|
MedChemexpress LLC
|
LY2955303 [CAS 1433497-19-8]
|
|
COVID-19-immunoregulation
|
|
HY-107765-50mg
|
MedChemexpress LLC
|
LY2955303 [CAS 1433497-19-8]
|
|
COVID-19-immunoregulation
|
|
HY-107765-1mL
|
MedChemexpress LLC
|
LY2955303 [CAS 1433497-19-8] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-B0574-10g
|
MedChemexpress LLC
|
Mefenamic acid [CAS 61-68-7]
|
|
COVID-19-immunoregulation
|
|
HY-B0574-5g
|
MedChemexpress LLC
|
Mefenamic acid [CAS 61-68-7]
|
|
COVID-19-immunoregulation
|
|
HY-B0574-500mg
|
MedChemexpress LLC
|
Mefenamic acid [CAS 61-68-7]
|
|
COVID-19-immunoregulation
|
|
HY-B0574-1mL
|
MedChemexpress LLC
|
Mefenamic acid [CAS 61-68-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-B0574S-1mg
|
MedChemexpress LLC
|
Mefenamic acid-d4 [CAS 1216745-79-7]
|
|
COVID-19-immunoregulation
|
|
HY-B0574S-5mg
|
MedChemexpress LLC
|
Mefenamic acid-d4 [CAS 1216745-79-7]
|
|
COVID-19-immunoregulation
|
|